Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. freshman Avg
|
|
New words:
accreted, accretion, addressing, alert, auction, authoritative, back, bile, Codification, condensed, contractor, deconsolidated, deferral, departure, dismissing, distinguish, enroll, furniture, GAAP, Galectin, greenberg, invoice, LP, mezzanine, permanent, rationale, remeasurement, repricing, revert, shorter, single, unadjusted, unknown
Removed:
adjusting, alternative, anomeric, APB, argument, array, art, attended, attention, attracting, binding, binomial, biochemical, biologically, body, bond, branching, calculating, capable, capacity, claimed, complexity, component, Contingency, deciphered, defamation, defense, estimable, estimation, extraordinarily, factoring, feasibility, FIN, FSP, function, great, injunctive, inter, interference, Interpretation, invention, Lastly, lectin, linkage, liquid, liquidation, Marlborough, misappropriation, molecular, monetary, multiple, nucleic, orientation, paragraph, permitted, physiological, planning, pool, prescribed, realizable, rejected, relief, restated, retaining, revise, sequencing, shape, signal, spread, structural, task, taxing, technically, translate, unambiguously, understood, unfair, variation, vast, working, wrote
Filing tables
Filing exhibits
- 10-K Annual report
- 21.1 Subsidiaries of Pro-pharmaceuticals, Inc.
- 23.1 Consent of Caturano and Company, PC
- 31.1 Certification of CEO Pursuant to Section 302
- 31.2 Certification of CFO Pursuant to Section 302
- 32.1 Certification of CEO Pursuant to Section 906
- 32.2 Certification of CFO Pursuant to Section 906
GALT similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-116629 and 333-109893 on Form S-8 of our report dated March 12, 2010 (which report expresses an unqualified opinion and includes explanatory paragraphs relating to the substantial doubt about the Company’s ability to continue as a going concern as discussed in Note 1 and the change in the manner in which the Company accounts for certain warrants as discussed in Note 8), appearing in this Annual Report on Form 10-K of Pro-Pharmaceuticals, Inc. for the year ended December 31, 2009.
/s/ Caturano and Company, P.C.
Boston, Massachusetts
March 12, 2010